A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack
This study has been terminated.
Sponsor:
Arginox Pharmaceuticals
Information provided by:
Arginox Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00112281
First received: June 1, 2005
Last updated: August 2, 2006
Last verified: May 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | January 2007 |
| Estimated Primary Completion Date: | No date given |
No publications provided by Arginox Pharmaceuticals
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):